Published in Anesth Pain Med on January 18, 2016
Patient survival after human albumin administration. A meta-analysis of randomized, controlled trials. Ann Intern Med (2001) 4.96
Safety of modern starches used during surgery. Anesth Analg (2012) 3.27
Effect of hydroxyethyl starch on bleeding after cardiopulmonary bypass: a meta-analysis of randomized trials. J Thorac Cardiovasc Surg (2012) 2.36
Comparison of the effects of albumin 5%, hydroxyethyl starch 130/0.4 6%, and Ringer's lactate on blood loss and coagulation after cardiac surgery. Br J Anaesth (2013) 2.25
Albumin administration is associated with acute kidney injury in cardiac surgery: a propensity score analysis. Crit Care (2014) 1.88
Albumin versus hydroxyethyl starch in cardiopulmonary bypass surgery: a meta-analysis of postoperative bleeding. Ann Thorac Surg (2001) 1.74
Gelatin and hydroxyethyl starch, but not albumin, impair hemostasis after cardiac surgery. Anesth Analg (2006) 1.68
Cardiopulmonary bypass-associated acute kidney injury. Anesthesiology (2011) 1.58
The pathophysiology of cardiac surgery-associated acute kidney injury (CSA-AKI). Int J Artif Organs (2008) 1.53
Hydroxyethyl starch: safe or not? Anesth Analg (1997) 1.52
A triple-blinded randomized trial comparing the hemostatic effects of large-dose 10% hydroxyethyl starch 264/0.45 versus 5% albumin during major reconstructive surgery. Anesth Analg (2005) 1.49
Six percent hydroxyethyl starch 130/0.4 (Voluven®) versus 5% human serum albumin for volume replacement therapy during elective open-heart surgery in pediatric patients. Anesthesiology (2013) 1.49
Does intraoperative hetastarch administration increase blood loss and transfusion requirements after cardiac surgery? Anesth Analg (2000) 1.48
Coagulopathy induced by hydroxyethyl starch. Anesth Analg (1997) 1.47
Hemostatic effects of three colloid plasma substitutes for priming solution in cardiopulmonary bypass. Eur J Cardiothorac Surg (1997) 1.46
A novel hydroxyethyl starch (Voluven) for effective perioperative plasma volume substitution in cardiac surgery. Can J Anaesth (2000) 1.34
Sample size estimation in clinical trial. Perspect Clin Res (2010) 1.28
Effects of different plasma substitutes on blood coagulation: a comparative review. Crit Care Med (2001) 1.26
Hydroxyethyl starch as a priming solution for cardiopulmonary bypass impairs hemostasis after cardiac surgery. Anesth Analg (2004) 1.17
Comparing the effects of 5% albumin and 6% hydroxyethyl starch 130/0.4 on coagulation and inflammatory response when used as priming solutions for cardiopulmonary bypass. Minerva Anestesiol (2010) 1.15
Voluven, a lower substituted novel hydroxyethyl starch (HES 130/0.4), causes fewer effects on coagulation in major orthopedic surgery than HES 200/0.5. Anesth Analg (2001) 1.04
Hydroxyethyl starch versus Ringer solution in cardiopulmonary bypass prime solutions (a randomized controlled trial). J Cardiothorac Surg (2008) 0.96
Colloids versus crystalloids as priming solutions for cardiopulmonary bypass: a meta-analysis of prospective, randomised clinical trials. Acta Anaesthesiol Belg (2003) 0.91
Hydroxyethyl starch 130/0.4 versus modified fluid gelatin for cardiopulmonary bypass priming: the effects on postoperative bleeding and volume expansion needs after elective CABG. Acta Anaesthesiol Belg (2009) 0.90
Intraoperative hetastarch infusion impairs hemostasis after cardiac operations. Ann Thorac Surg (1997) 0.85
Effect of hydroxyethylstarch on renal function in cardiac surgery: a large scale retrospective study. Acta Anaesthesiol Belg (2005) 0.84
The Effect of Intravenous Administration of Active Recombinant Factor VII on Postoperative Bleeding in Cardiac Valve Reoperations; A Randomized Clinical Trial. Anesth Pain Med (2015) 0.83
Profound effects of cardiopulmonary bypass priming solutions on the fibrin part of clot formation: an ex vivo evaluation using rotation thromboelastometry. J Cardiothorac Vasc Anesth (2010) 0.80
Comparison of three plasma expanders used as priming fluids in cardiopulmonary bypass patients. Perfusion (1998) 0.79
Equivalent efficacy of hydroxyethyl starch 130/0.4 and human serum albumin: if nothing is the same, is everything different? The importance of context in clinical trials and statistics. Anesthesiology (2013) 0.77
Does priming implementation with low-dose albumin reduce postoperative bleeding following cardiopulmonary bypass? Int J Artif Organs (2003) 0.77
Factors affecting on serum lactate after cardiac surgery. Anesth Pain Med (2014) 0.76
Senile Calcification of the Trachea, Aortic Arch, and Mitral Annulus: An Incidental Finding on Chest X-Ray. J Tehran Heart Cent (2015) 0.75
Primary Cardiac Synovial Sarcoma: A Case Report. J Tehran Heart Cent (2017) 0.75